Floatz logo

1H-3-BENZAZEPIN-7-OL, 5-(7-BENZOFURANYL)-8-CHLORO-2,3,4,5-TETRAHYDRO-3-METHYL-, (5S)-

Colorectal Cancer

University Hospital, LimogesSmall moleculePhase 3Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
48/ 100
Competitive Position
59/ 100

Competitive context

482 Active assets in the Colorectal Cancer cohort.

Asset / SponsorPhaseRating
Calcium folinate pentahydrate
UNICANCER
Phase 4BB
PANITUMUMAB
MSPU des 3 Provinces
Phase 3BB
Levoleucovorin
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3BB
FLUOROURACILUM
UNICANCER
Phase 4BB
Eloxatin
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 4BB

View all 50 →

Same molecule, other indications

1H-3-BENZAZEPIN-7-OL, 5-(7-BENZOFURANYL)-8-CHLORO-2,3,4,5-TETRAHYDRO-3-METHYL-, (5S)- is also rated in:

Alzheimer DementiaDormant
BB
Indicative ·
66 / 100
View asset →
Essential TremorDormant
B
Indicative ·
63 / 100
View asset →
Breast CancerDormant
B
Indicative ·
58 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →